Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 273(2): 736-44, 2000 Jul 05.
Article in English | MEDLINE | ID: mdl-10873673

ABSTRACT

This study aims to elucidate the signaling pathway for insulin-like growth factor-1 (IGF-1) in cultured neonatal rat cardiomyocytes and particularly the role of IGF-1 in cardiac apoptosis. IGF-1 stimulated polyphosphoinositide turnover, translocation of protein kinase C (PKC) isoforms (alpha, epsilon, and delta) from the soluble to the particulate fraction, activation of phospholipid-dependent and Ca(2+)-, phospholipid-dependent PKC, and activation of the extracellular-regulated kinase (ERK). IGF-1 attenuated sorbitol-induced cardiomyocyte viability and nuclear DNA fragmentation. These antiapoptotic effects of IGF-1 were blocked by PD-098059 (an MEK inhibitor) but not by bisindolylmaleimide I (BIM, a specific PKC inhibitor). The ERK pathway may therefore be an important component in the mechanism whereby IGF-1 exerts its antiapoptotic effect on the cardiomyocyte.


Subject(s)
Insulin-Like Growth Factor I/pharmacology , Mitogen-Activated Protein Kinases/metabolism , Protein Kinase C/metabolism , Animals , Apoptosis/drug effects , Cells, Cultured , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , Hydrolysis , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinase Kinases/metabolism , Myocardium/cytology , Myocardium/metabolism , Osmotic Pressure , Phosphatidylinositols/metabolism , Protein Kinase C/antagonists & inhibitors , Rats , Signal Transduction/drug effects
2.
Life Sci ; 64(18): 1603-12, 1999.
Article in English | MEDLINE | ID: mdl-10328520

ABSTRACT

There is some evidence that cardiac rather than circulating insulin-like growth factor-1 (IGF-1) levels contribute to the development of renovascular hypertensive left ventricular hypertrophy (LVH), remaining unknown the effects of antihypertensive drugs on IGF-1 levels. We have assessed here the preventive effects of enalapril, losartan, propanolol and alpha-methyldopa on left ventricle (LV) and circulating IGF-1 levels in a rat model of hypertension and LVH (Goldblatt, GB). Our results show that relative LV mass and the LV content of IGF-1 were significantly lower with all antihypertensive drugs in GB rats (p<0.001). Serum concentrations of IGF-1 were lower in GB rats treated with enalapril, alpha-methyldopa and propanolol (p<0.01), but not in those treated with losartan. These results support the hypothesis that local rather than seric IGF-1 contributes to the development of left ventricular hypertrophy induced by pressure overload in the rat.


Subject(s)
Antihypertensive Agents/pharmacology , Heart/drug effects , Hypertrophy, Left Ventricular/prevention & control , Insulin-Like Growth Factor I/metabolism , Myocardium/metabolism , Animals , Blood Pressure/drug effects , Enalapril/pharmacology , Losartan/pharmacology , Male , Methyldopa/pharmacology , Propranolol/pharmacology , Radioimmunoassay , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...